FDA Approves Pfizer's COVID-19 Vaccine Emergency Use Despite Fears From Severe Allergic Reactions Reported in UK
10 December 2020, 7:49 pm EST By The United States Food and Drug Administration (FDA) Key Panel recently expressed their approval on the Emergency Use Authorization of Pfizer and BioNTech's 95 percent effective COVID-19 Vaccine. Deliberations would still come within the FDA, especially with the Pfizer vaccine causing a severe allergic reaction to patients who received the UK's immunization shot. News regarding the talks of COVID-19 vaccine in the country is now leading towards one of the largest pharmaceutical companies globally, Pfizer, who worked with BioNTech with an mRNA designed shot...